LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026)
LivaNova's (LIVN) quarterly Other Non-Current Liabilities came in at $152.9 million in Q2 2026, up 190.15% year-over-year from $52.7 million in Q2 2025, and up 48.84% quarter-over-quarter from $102.7 million in Q1 2026.
Analysis
LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova has disclosed Other Non-Current Liabilities across 12 years of filings, most recently posting $152.9 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities rose 190.15% year-over-year to $152.9 million; the TTM figure through Jun 2026 stood at $152.9 million (up 190.15% YoY), while the FY2025 annual figure was $92.1 million, up 9.33% from the prior year.
- Other Non-Current Liabilities came in at $152.9 million for Q2 2026 at LivaNova, up from $102.7 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $170.7 million in Q1 2022 to a low of $52.7 million in Q2 2025.
- Average Other Non-Current Liabilities over 5 years is $97.9 million, with a median of $90.8 million recorded in 2022.
- Year-over-year, Other Non-Current Liabilities plunged 50.01% in 2025 and soared 190.15% in 2026.
- Over 5 years, Other Non-Current Liabilities stood at $91.6 million in 2022, then fell by 11.64% to $80.9 million in 2023, then gained by 4.1% to $84.2 million in 2024, then climbed by 9.33% to $92.1 million in 2025, then soared by 66.06% to $152.9 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $152.9 million in Q2 2026, $102.7 million in Q1 2026, and $92.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 152.90 Mn |
| Mar 31, 2026 | 102.73 Mn |
| Dec 31, 2025 | 92.08 Mn |
| Sep 30, 2025 | 64.52 Mn |
| Jun 30, 2025 | 52.70 Mn |
| Mar 31, 2025 | 85.14 Mn |
| Dec 31, 2024 | 84.22 Mn |
| Sep 30, 2024 | 84.16 Mn |
| Jun 30, 2024 | 105.41 Mn |
| Mar 31, 2024 | 104.92 Mn |
| Dec 31, 2023 | 80.90 Mn |
| Sep 30, 2023 | 89.81 Mn |
| Jun 30, 2023 | 92.63 Mn |
| Mar 31, 2023 | 90.12 Mn |
| Dec 31, 2022 | 91.56 Mn |
| Sep 30, 2022 | 83.15 Mn |
| Jun 30, 2022 | 134.09 Mn |
| Mar 31, 2022 | 170.66 Mn |
| Dec 31, 2021 | 86.83 Mn |
| Sep 30, 2021 | 104.08 Mn |